Hospice News May 29, 2024
Jim Parker

The U.S. Centers for Medicare & Medicaid Services (CMS) may not have accounted for the financial and administrative burdens associated with its implementation of the Hospice Outcomes and Patient Evaluation (HOPE) Tool.

In comments on the 2025 proposed hospice rule, the National Hospice and Palliative Care Organization (NHPCO) voiced concerns that the agency’s regulatory impact assessment may not have taken all the details into account, including the need for staffing and technology investments.

“Clinical and administrative cost calculations do not align with the reality of the true costs of implementation,” NHPCO indicated in a letter to CMS. “In the proposed rule, CMS significantly underestimated the burden and costs hospices will incur to comply with HOPE requirements. The agency’s estimated cost...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Health IT, Post-Acute Care, Provider, Technology
CMS proposes new guardrails on Medicare Advantage prior authorizations, marketing
CMS finalizes new kidney transplant model: 10 things to know
CMS' proposed changes to Medicare Advantage: 10 things to know
Medicare Advantage Plans' Prior Auth Rules Would Be Made Public Under CMS Proposal
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule

Share This Article